Our business is focused on rapid development of break-through pharmaceutical products based on mitochondria targeted antioxidants. The unique experimentally proved properties of these molecules make them promising drug candidates for treatment of many age-related disorders. Mitotech is developing its technology with a goal to help millions of patients suffering from ophthalmic, neurodegenerative, cardiovascular, metabolic and rare genetic disorders.

Drug discovery pipeline